HYB-220

N/A

Report date: 2023/06/14 09:10:56

NME

Base Information

Drug NameHYB-220

Drug Alias NameGEM-220HYB220HYB-676

ClassificationSmall molecules

Mechanisms of ActionVascular endothelial growth factor A inhibitorsAngiogenesis inhibitors

TargetsVascular endothelial growth factor A

Therapy Area/IndicationsEye DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesItaly

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAceragen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAceragen Inc

Active IndicationsN/A

Inactive IndicationsEye DiseasesNeoplasms

ATC CodeN/A